
==== Front
Eur J Nutr
Eur J Nutr
European Journal of Nutrition
1436-6207
1436-6215
Springer Berlin Heidelberg Berlin/Heidelberg

38753174
3423
10.1007/s00394-024-03423-w
Original Contribution
Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal
http://orcid.org/0000-0003-1313-7762
Kruger Johanita johanita.kruger@nutres.de
https://www.nutrition-research.de

12
Sus Nadine 1
Moser Andrea 1
Scholz Sophie 1
Adler Guenther 1
Venturelli Sascha 1
Frank Jan 1
1 https://ror.org/00b1c9541 grid.9464.f 0000 0001 2290 1502 Institute of Nutritional Sciences, University of Hohenheim, Garbenstraße 28, 70599 Stuttgart, Germany
2 https://ror.org/00g0p6g84 grid.49697.35 0000 0001 2107 2298 Department of Consumer and Food Sciences and Institute of Food Nutrition and Well-Being, University of Pretoria, Hatfield, Private Bag X20, Pretoria, 0028 South Africa
16 5 2024
16 5 2024
2024
63 6 22612270
20 6 2023
8 5 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Purpose

The original aim of the study was to determine, in a double-blind 3-arm crossover human trial (n = 7), the effect of supplemental levels of iron (25 mg) and zinc (30 mg) on β-carotene (synthetic) bioavailability (10 h postprandial). However, despite the high dose of supplemental β-carotene (15 mg) consumed with the high fat (18 g), dairy-based breakfast test meal, there was a negligible postprandial response in plasma and triglyceride rich fraction β-carotene concentrations. We then systematically investigated the possible reasons for this low bioavailability of β-carotene.

Methods

We determined (1) if the supplemental β-carotene could be micellised and absorbed by epithelial cells, using a Caco-2 cell model, (2) if the fat from the test meal was sufficiently bioavailable to facilitate β-carotene bioavailability, (3) the extent to which the β-carotene could have been metabolised and converted to retinoic acid/retinol and (4) the effect of the test meal matrix on the β-carotene bioaccessibility (in vitro digestion) and Caco-2 cellular uptake.

Results

We found that (1) The supplemental β-carotene could be micellised and absorbed by epithelial cells, (2) the postprandial plasma triacylglycerol response was substantial (approximately 75–100 mg dL−1 over 10 h), indicating sufficient lipid bioavailability to ensure β-carotene absorption, (3) the high fat content of the meal (approximately 18 g) could have resulted in increased β-carotene metabolism, (4) β-carotene bioaccessibility from the dairy-based test meal was sixfold lower (p < 0.05) than when digested with olive oil.

Conclusion

The low β-carotene bioavailability is probably due to a combination of the metabolism of β-carotene to retinol by BCMO1 and interactions of β-carotene with the food matrix, decreasing the bioaccessibility.

Trail registration

The human trail was retrospectively registered (ClinicalTrail.gov ID: NCT05840848).

Supplementary Information

The online version contains supplementary material available at 10.1007/s00394-024-03423-w.

Keywords

Bioaccessibility
Cellular uptake
Divalent minerals
Food matrix
Lipid profile
Micellization
Dairy
BCMO1
http://dx.doi.org/10.13039/100005156 Alexander von Humboldt-Stiftung Universität Hohenheim (3153)Open Access funding enabled and organized by Projekt DEAL.

issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmcIntroduction

Optimal carotenoid bioavailability is important as carotenoids function as provitamin A and/or antioxidants. β-carotene, from plant-based diets is often the main source of vitamin A, either due to socio-economic status (cannot afford animal products) or personal choice (vegetarianism/veganism). Epidemiological studies have shown a positive link between dietary intake as well as tissue concentrations of carotenoids and a lower risk of chronic disease [1], and dietary or circulating beta-carotene has also been inversely associated with risk of all-cause mortality [2].

The initial aim of the study was to determine the effects of dietary supplements of iron (25 mg) and zinc (30 mg) on β-carotene and lipid bioavailability in healthy male volunteers. Decreased bioaccessibility and cellular uptake observed in In vitro studies [3–5], suggest that supplemental levels of divalent minerals could inhibit the bioavailability of β-carotene in humans [3–5]. The decreased bioaccessibility and cellular uptake in these studies were mainly attributed to the divalent minerals capacity to precipitate bile acids and decrease the stability of physiological mixed micelles. Three in vivo studies that have investigated the effects of supplemental levels of calcium and iron on the bioavailability of carotenoids in healthy adults had contradictory findings [6–8].

However, despite the high dose of β-carotene consumed with the test meal (15 mg), there was a negligible postprandial response in plasma and triglyceride rich fraction (TRF) β-carotene concentrations. We then systematically investigated the possible reasons for the low bioavailability of β-carotene observed. For β-carotene to be bioavailable various steps are required, including (1) release from the food matrix, (2) incorporation into physiological mixed micelles, (3) uptake by intestinal epithelial cells, and (4) packaging into chylomicrons that are secreted into the lymphatic system [9].

We evaluated the effects various factors could have on these steps, resulting in low bioavailability. First, we determined if the β-carotene was released from the capsule and if the supplemental β-carotene was in a form that could be included in micelles and be absorbed by epithelial cells. The crystalline form of carotene has been found to decrease both the bioaccessibility and bioavailability of carotenes [10]. Secondly, by evaluating the post-prandial triacylglycerol (TAG) response, we evaluated if the fat from the test meal was sufficiently digested and absorbed to facilitate β-carotene absorption and/or transport into the lymphatic system. The amount of fat (5–28 g) in a meal and its digestion is critical to ensure optimal micellization and absorption of β-carotene [9, 11, 12]. We then investigated the extent to which the β-carotene could have been metabolised and converted to retinoic acid/retinol during absorption, by evaluating the post-prandial retinol response. Dietary factors can affect the activity of BCMO1, resulting in more or less of the absorbed β-carotene being converted [13]. Lastly, using in vitro digestion and Caco-2 cell culture models, we evaluated the effect of the test meal matrix on the β-carotene bioaccessibility and cellular uptake.

Materials and methods

Sample size calculation and study population

The required power for the study was calculated based on the area under the plasma β-carotene concentration–time curve (AUC). The study power was calculated based on the following formula: n > F (σ/d)2, where n = number of subjects, σ = standard deviation of the dependent primary outcome measure, d = difference between control and treatment classified as significantly different in the literature. The corresponding F-value of 20.86 at P < 0.025 and 99% power were used [14].

In a comparable study by (Goltz et al. 2013), an AUC of 22.6 ± 7.6 nmol L−1 h could be determined after intake of 20–30 mg β-carotene from one meal (n = 6). Based on these reference values, a mean value of 22.6 nmol L−1 h and a standard deviation of 7.6 nmol L−1 h was used in the calculation. A 50% reduction in bioavailability would mean a biologically relevant effect, which is why a significant difference of 11.3 nmol L−1 h was used for the calculation. Thus, n > 20.86 × (7.6/11.3)2 resulted in a number of at least 9.44, rounded up to ten subjects. Since this was a cross-over study with no gender effects and considering average drop-out rates observed in previous studies, 12 participants were included in the study.

After screening 23 males, a total of twelve healthy male participants (aged 18–45 years old) with routine blood chemistry values within the normal ranges (Supplemental Table A1) and who met the inclusion criteria were included in this study. Women were excluded from the study because the concentrations and distribution of carotenoids in the lipoprotein fractions fluctuate throughout the menstrual cycle [15, 16]. Other exclusion criteria were overweight (BMI > 25 kg m−2), metabolic and endocrine diseases, drug abuse, use of dietary supplements or any form of medication, smoking, frequent alcohol consumption (> 20 g ethanol day−1), adherence to a restrictive dietary regimen, physical activity of more than 5 h/week, participation in a clinical trial within the past 3 months prior to recruitment, or a known intolerance against β-carotene, iron and/or zinc supplements. All participants were asked to maintain their regular lifestyles and usual extent of physical activities during the study period. The study protocol (AZ: F-2017-039) was approved by the ethics committee of the State Medical Society of Baden-Wuerttemberg, Germany, and was in conformance with the Declaration of Helsinki. Written informed consent was obtained from all participants before inclusion in the trial.Table 1 Composition and time of consumption (relative to the intake of β-carotene preparations at 0 h) of standardised meals

Meal	Time (h)	Composition	
Dinner	−10	Refined white bread, camembert, butter, macadamia nut, coconut yoghurt	
Breakfast	0	Refined white bread roll, medium fat cream cheese, Greek yoghurt with honey	
Lunch	4	Pasta with white cheese sauce, bread roll, yoghurt ice cream	
Snack	6	Coffee or tea, coconut macaroons	
Dinner	8	Refined white bread, butter, potato salad, almonds, white hazelnut yoghurt	

Study design and dosage information

The study followed a double-blind crossover design with three study arms separated by one-week washout periods. In short, the participants were asked to follow a diet low in carotenoids by avoiding all orange, yellow, red and green fruits and vegetables for four days. This was followed by three days of a strictly carotenoid-free diet, which only allowed foods from a specified list (Table 1). On each study day, β-carotene was administered in the morning after a > 10 h overnight fast (Supplemental Fig. A1). All participants orally ingested, in random order, a single dose of 15 mg synthetic β-carotene in a soybean/corn oil matrix (BIOVEA) with either a placebo (empty capsule), 25 mg iron (FeSO4; Woerwag Pharma GmbH & Co. KG, Boeblingen, Germany) or 30 mg zinc (ZnSO4; Woerwag Pharma) capsule. The iron and zinc concentrations were chosen considering the tolerablr upper limit of intake, suggested maximum levels in supplements as well as average iron and zinc contents of supplements in the Europe market. A standardised dinner was provided on the evening before the trial and standardised meals were provided during the entire intervention day (Table 1). On the first of three study days, if the amount of food (weight or volume) consumed by each participant varied at all from the standardised meal, it was recorded and the same amounts provided during the following two arms to ensure similar food, and especially fat consumption. Water was available unrestricted for consumption throughout the day. Blood samples were drawn from an indwelling venous cannula and collected at 0 h directly before β-carotene supplementation and then every hour for 10 h.Fig. 1 Mean (A) plasma β-carotene, (B) TRF β-carotene, plasma (C) TAG and (D) retinol concentrations (mean ± SD) over the course of 10 h after a single oral dose of 15 mg β-carotene together with a placebo, iron sulphate (25 mg iron) or zinc sulphate (30 mg zinc). Differences between groups (n = 6) were analysed by one way ANOVA, but no significant differences were observed

Blood sampling and processing

For the determination of plasma concentrations of β-carotene, LDL- and HDL-cholesterol, and triacylglycerols (TAG), blood was collected in tubes containing EDTA (Sarstedt AG & Co, Nuebrecht, Germany) and immediately centrifuged (3000×g, 10 min, 4 °C). From the obtained plasma samples, three aliquots were stored at − 80 °C until further analysis and the rest ultracentrifuged to obtain the triacylglycerol-rich fraction (TRF). For the analyses of liver and kidney function markers, plasma and serum were obtained from blood sampled at the 0- and 4-h time points.

The TRF was prepared according to [11]. Briefly, plasma (3.5 mL) was transferred to an ultracentrifuge tube and carefully overlaid with 8 mL 1.3% sodium chloride and then ultracentrifuged (Beckman Coulter, OptimaTM L-80 XP Ultracentrifuge) using a swinging bucket rotor (SW41Ti) at 150,000×g for 1 h at 4 °C. Afterwards, the TRF was isolated by transferring the upper ~ 6 mL by pipette, which was then overlaid with nitrogen gas to minimize oxidation and stored at −80 °C until extraction.

β-Carotene analysis in plasma and TRF

The plasma samples were randomly extracted and analysed by HPLC according to [17]. Briefly, 40 µL plasma was extracted with an ethanol/n-butanol mixture (50:50) containing apo-80-carotenal-methyloxime [12 µL/100 mL; Fluka Analytical (Merck Group KGaA), Darmstadt, Germany] as internal standard. After centrifugation, the clear supernatant was analysed by HPLC.

The TRF was extracted and analysed by HPLC [17]. For the extraction, 100 µL apo-80-carotenal-methyloxime (12 µL/100 mL) and 2 mL ethanol (for deproteination) were added to 3 mL of the TRF and vortexed for 30 s. The solution was extracted twice with 2 mL hexane. The hexane layers were removed, combined and evaporated in a centrifugal vacuum concentrator (Christ, RVC 2–25 CD plus) and the dried sample re-dissolved in 100 µL acetonitrile and immediately analysed by HPLC.

Both the plasma and TRF samples were analysed using a Shimadzu HPLC (LC-10AD) equipped with a UV–Vis detector (SPD 20A, set at 450 nm). Carotenoids were separated using a ReproSil 80 ODS-2 column (3 µm, 250 × 4.6 mm; Dr. Maisch GmbH, Ammerbuch, Germany) at 40 °C and an eluent in recirculation mode [82% acetonitrile, 15% 1,4-dioxin, and 3% methanol (vol/vol) containing 100 mM ammonium acetate and 10 mM trimethylamine] at a flow rate of 1.5 mL min−1 [17]. A β-carotene standard (≥ 97.0% purity, Sigma-Aldrich) was used to construct a standard curve.

Analysis of triacylglycerols, HDL- and LDL-cholesterol

Plasma TAG, HDL- and LDL-cholesterol were analysed by a clinical laboratory (Laborärzte Sindelfingen, Sindelfingen, Germany).

Caco-2 cellular uptake assay

The cellular uptake and transepithelial transport (apical to basolateral) of β-carotene from the dietary supplement (β-carotene oil) and a pure synthetic powder (β-carotene powder; Sigma Aldrich, Darmstadt, Germany) was determined using a Caco-2 cell model [18]. In short, Caco-2 cells (HTB-37, ATCC, Wessel, Germany) were cultured in Dulbecco’s Modified Eagle Medium (Sigma-Aldrich) containing 10% foetal bovine serum, 1% sodium pyruvate, 1% nonessential amino acids, and 1% penicillin and streptomycin (all from Carl Roth, Karlsruhe, Germany). Cells were seeded in Transwell membrane inserts (Corning, Kaiserslautern, Germany) at 5 × 104 cells per well and all experiments conducted between passages 12 and 20. The β-carotene oil and β-carotene powder were micellized, using Polysobate 80, according to O'Sullivan et al.[19]. On the day of the experiment, (20–22 days post-confluence) the integrity of the cell monolayer was monitored and all wells with a transepithelial electrical resistance (TEER) less than 250 Ω cm2 were discarded. The micellized β-carotene solutions (500 µL) were diluted with modified fasted state simulated intestinal fluid (FaSSIF) transport buffer [20] to a concentration of 100 µM (equivalent to a 15 mg dose taken with 250 mL water), applied to the Caco-2 cells (apical chamber) and incubated for 90 min. To create “sink conditions” in the basolateral compartment, 4% bovine serum albumin was used [21]. To simulate the transport of absorbed compounds in the lymphatic system and away from the intestinal cells, the receiver fluid (1200 μL) in the basolateral chamber was replaced by an equal volume of fresh solution at 15, 30, 45, 60 and 90 min. Finally, the donor fluid in the apical chamber (500 μL), cells (cellular uptake) and pooled basolateral samples (transepithelial transport) were extracted and analysed by HPLC as described for the TRF. In this study cellular uptake and transepithelial transport is defined as the percentage of β-carotene retained by the Caco-2 cells and transported to the basolateral compartment, respectively, as percentage of the total amount of β-carotene applied to the cells.

β-Carotene solubility and bioaccessibility

To determine the effect of the test meal (breakfast, Table 1) matrix on the bioaccessibility of β-carotene, an in vitro gastrointestinal digestion was performed [22]. The digestive enzymes and bile used in the in vitro digestion; pepsin from porcine gastric mucosa (P7000; ≥ 250 units mg−1), pancreatin from porcine pancreas (P7545; 8xUSP specification), porcine bile (B8631) and lipase from porcine pancreas Type II (L3126) were obtained from Sigma-Aldrich. A whole serving of the test meal, with which the β-carotene and mineral supplements were consumed during the human study, was combined and blended into a rough paste. The total weight of the meal was 270 g with a fat content of 6.7% or 18 g (calculated from the nutritional information on the packaging). A simulated digestion of a 15 mg dose β-carotene dose taken together with the whole meal (500 µg β-carotene + 9.0 g meal purée) or with only olive oil (500 µg β-carotene + 0.6 g olive oil + 8.4 g saline) was performed. The olive oil added was equal to the amount of fat in the test meal (6.7% of 9.0 g). The 15 mg β-carotene was either from the supplement (β-carotene oil) or the pure synthetic powder (β-carotene powder).

For each digestion (final volume made up to 25 mL with saline), β-carotene (500 μg) with the meal purée (9.0 g) or olive oil/saline (0.6/8.4 g) was digested with porcine pepsin (4.9 mg mL−1; Sigma Aldrich) at a pH of 2.5 for 1 h at 37 °C, shaking at 180 rpm. Porcine pancreatin (1.2 mg mL−1), porcine pancreatic lipase (0.6 mg mL−1), and porcine bile extract (7.2 mg mL−1; all from Sigma Aldrich) were added and the pH adjusted to 6.5. The samples were covered by nitrogen gas and incubated for 2 h, as described above. The digested samples were then centrifuged (13,500×g, 60 min, 4 °C), and a subsample of the supernatant was collected and analysed to determine the amount of solubilised β-carotene. The soluble fraction would include bile salt–lipid micelles as well as larger undigested lipid emulsions, which are less physiologically relevant to β-carotene absorption. The remainder of the soluble fraction was filtered (Filtropur S, 0.2 μm, Sarstedt, Nümbrecht, Germany) to separate small bile salt–lipid mixed micelles from the larger lipid emulsions. Both the centrifuged and filtered samples were topped with nitrogen gas and stored at − 80 °C for a maximum of 1 week prior to saponification and HPLC analysis [5]. In this paper, the in vitro solubility is defined as the amount of β-carotene solubilised (supernatant after centrifuging) and bioaccessibility as the amount incorporated into small particles/micelles (supernatant after centrifuging and filtration, 200 nm) after in vitro digestion.

Statistical analyses

The primary outcomes analysed from the clinical trial were: the area under the plasma concentration–time curve (AUC), using the trapezoid rule, the maximum concentration in plasma (Cmax) and the time to reach the maximum concentration in plasma (Tmax). All data are presented as arithmetic mean ± standard deviation (SD). The results are reported both as measured (Table 2) and baseline-corrected data (Supplemental Table A3). Statistical analyses were calculated using GraphPad Prism 5 (GraphPad Software Inc., San Diego, California, USA). Group means of iron and zinc on blood parameters and differences in β-carotene cellular uptake, transepithelial transport (n = 9), β-carotene solubility and bioaccessibility (n = 4) were compared using one-way ANOVA, with p < 0.05 considered statistically significant.Table 2 Pharmacokinetic variables (mean ± SD) calculated from concentrations of β-carotene in triacylglycerol-rich fraction (TRF) and β-carotene, triacylglycerol (TAG), high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol concentrations in plasma (collected every hour for 10 h) of healthy human males after a single oral dose of 15 mg β-carotene together with a placebo, iron sulphate (25 mg iron) or zinc sulphate (30 mg zinc)

	β-Carotene	β-Carotene + iron	β-Carotene + zinc	
TRF	
 β-Carotene	
 AUC (nmol L−1 h)	73.4 ± 33.5	76.5 ± 22.3	77.5 ± 37.0	
 Cmax (nmol L−1)	17.2 ± 10.7	17.1 ± 14.5	18.8 ± 20.6	
 Tmax (h)	3.3 ± 4.5	1.8 ± 1.5	2.5 ± 3.2	
Plasma	
 β-Carotene	
 AUC (µmol L−1 h)	7.3 ± 3.3	7.9 ± 3.4	7.4 ± 3.3	
 Cmax (µmol L−1)	0.8 ± 0.4	1.0 ± 0.4	0.8 ± 0.4	
 Tmax (h)	5.3 ± 4.4	5.7 ± 3.0	4.3 ± 2.7	
TAG				
 AUC (mg dL−1 h)	1060.0 ± 429.9	1034.0 ± 324.7	973.0 ± 388.0	
 Cmax (mg dL−1)	153.1 ± 67.2	147.3 ± 43.9	133.3 ± 48.8	
 Tmax (h)	7.6 ± 3.3	9.1 ± 1.2	7.4 ± 1.6	
HDL-cholesterol	
 AUC (mg dL−1 h)	474.1 ± 68.4	496.4 ± 75.5	491.6 ± 74.5	
 Cmax (mg dL−1)	49.4 ± 7.3	52.1 ± 7.8	51.6 ± 7.6	
 Tmax (h)	6.6 ± 4.1	6.3 ± 3.2	6.4 ± 4.3	
LDL-cholesterol	
 AUC (mg dL−1 h)	1007.0 ± 248.2	1084.0 ± 251.1	1019.0 ± 230.9	
 Cmax (mg dL−1)	105.5 ± 25.8	113.7 ± 25.8	107.8 ± 24.8	
 Tmax (h)	1.5 ± 2.0	2.7 ± 1.8	2.3 ± 3.9	
Differences between groups (n = 6) were analysed for by one-way ANOVA, but no significant differences were observed (p > 0.05)

Results

Study population and baseline characteristics

Twelve healthy male participants were enrolled in the study, but only seven volunteers completed the trial. The reasons for terminating the study included personal reasons, a wisdom tooth operation and an ear infection. One of the participants who completed the study was excluded due to high baseline plasma and TRF β-carotene concentrations, indicating non-adherence to the wash-out diet. The anthropometric characteristics and fasting blood chemistry values of the 6 male participants included in the study are displayed in Supplemental Table A1.

β-Carotene bioavailability

Neither iron, nor zinc supplements taken simultaneously with β-carotene significantly affected β-carotene AUC, Cmax or Tmax in plasma or TRF (Table 2). More notable was that, despite the high dose of β-carotene consumed with the test meal (15 mg), there was a negligible postprandial response in plasma and TRF β-carotene concentrations (Fig. 1).

Cellular uptake of β-carotene from capsules

We analysed β-carotene in the capsules and found them to contain the amount of β-carotene as displayed on the label (> 7.5 mg all-trans β-carotene/capsule). The β-carotene oil was investigated under a microscope and no crystal-like structures were observed. The capsule also readily dissolved (< 5 min) at a stomach pH of 2.5, releasing the β-carotene oil and making it available for digestion. The Caco-2 cellular uptake and transepithelial transport of micellized β-carotene from the supplement oil (2.41 ± 0.19 & 22.09 ± 7.86%, respectively) and a pure (> 97%) β-carotene powder (3.98 ± 1.21 & 33.63 ± 6.60%, respectively) was then compared (Table 3) and found no significant difference.Table 3 Caco-2 cellular uptake and trans-epithelial transport (mean ± SD) of micellized β-carotene (100 µM) from a supplemental oil or pure powder (> 97%)

	β-Carotene oil	β-Carotene powder	
% Cellular uptake	2.41 ± 0.19	3.98 ± 1.21	
% Trans-epithelial transport	22.09 ± 7.86	33.63 ± 6.60	
Differences between β-carotene oil and powder (n = 9) were analysed for by one-way ANOVA, but no significant differences were observed (p > 0.05)

Metabolism of fat from meals consumed

The test meal contained approximately 18 g fat/meal (6.7%, w/w) and a triphasic curve was observed, with peaks at approximately 2 to 3 h after the breakfast, lunch and after afternoon snack, respectively (Fig. 1). The Cmax of plasma TAG, normalised to the baseline, was 78.7–97.3 mg dL−1 (Supplemental Table A3).

Possible conversion of β-carotene to retinol

There was no substantial change in the plasma retinol content during the 10 h after the consumption of the supplement and test meal (Fig. 1).

β-Carotene bioaccessibility from the test-meal compared to olive oil

The solubility and bioaccessibility of β-carotene from the supplement oil and a > 97% pure β-carotene powder, digested either with the test meal or with olive oil (equal to the amount of fat in the meal), was compared. After digestion with the test matrix, the solubilization (4.46–9.87 μM) and bioaccessibility (1.03–1.07 μM) of β-carotene was only 12–27% and 2.8–2.9%, respectively (Table 4). However, when digested with olive oil, the solubilization (8.74–13.48 μM) and bioaccessibility (4.79–6.42 μM) of β-carotene was 24–36% and 13–17%, respectively. This means that sixfold less β-carotene from the test meal was micellized compared to when it was digested with olive oil.Table 4 Solubilization and bioaccessibility (mean ± SD) of β-carotene (37 µM) from a supplemental oil or pure powder (> 97%) after an in vitro gastro-intestinal digestion with the test meal (breakfast) matrix or olive oil

Digest composition	β-Carotene oil	β-Carotene powder	
β-Carotene solubilization (μM)	
 Olive oil*	8.74 ± 0.47b	13.48 ± 1.96c	
 Test meal**	4.46 ± 0.48a (−47%)	9.87 ± 0.49b (−27%)	
β-Carotene bioaccessibility (μM)	
Olive oil	6.42 ± 0.12b	4.79 ± 1.86b	
Test meal	1.03 ± 0.41a (−84%)	1.07 ± 0.49a (−78%)	
*Olive oil was added at the same concentration as the fat in the test meal (24 mg mL−1 digest)

**See Supplemental Table A2 for test meal (breakfast) composition

abcMeans of solubilisation/bioaccessibility results across lines and columns with different superscript letters are statistically different at p < 0.05 as analysed by ANOVA (n = 4)

()Differences in β-carotene solubilisation respective to bioaccessibility when digested with the test meal are given as the percentage of that digestion with olive oil

Discussion

β-Carotene bioavailability

The lack in β-carotene response could have been caused by multiple factors; (1) the β-carotene from the supplement was not bioavailable, (2) the fat from the test meal was insufficient/ineffective in facilitating β-carotene absorption and/or transport into the lymphatic system, (3) host factors affected the β-carotene absorption or the metabolism and conversion to retinoic acid/retinol during absorption or (4) the test meal matrix decreased the β-carotene bioaccessibility. Below we systematically investigated these possibilities.

Cellular uptake of β-carotene from capsules

To determine if the enterocytes could absorb the beta-carotene independent from its bioaccessibility, the supplement was micellized, using polysorbate 80. While the cellular uptake and transepithelial transport of β-carotene from the powder was slightly higher than that from the oil, the difference was not statistically significant and would not explain the lack of response in plasma and TRF β-carotene concentrations.

Metabolism of fat from meals consumed

To evaluate the metabolism of fat from the test meal (breakfast) and subsequent meals consumed on the study days, the plasma TAG response was evaluated. The test meal contained enough lipid (18 g fat/meal (6.7%, w/w)) to ensure optimal micellization and absorption of β-carotene [11, 12]. Lipid metabolism is critical to β-carotene metabolism, which includes (1) release from the food matrix, (2) incorporation into physiological mixed micelles, (3) uptake by intestinal epithelial cells, and (4) packaging into chylomicrons that are secreted into the lymphatic system. The triphasic curve confirmed lipid micellization, absorption, and transport into the lymphatic system (Fig. 1) and the high Cmax of plasma TAG, sufficient lipid bioavailability during the day to ensure β-carotene absorption.

β-Carotene metabolism during absorption

Even though the consumption of supplements were an exclusion criterion, it could be possible that the participants still had high vitamin A status, resulting in decreased β-carotene absorption [23]. In humans, between 35 and 90% of absorbed all-trans β-carotene is oxidatively cleaved by the β,β-carotene 15,15’-monooxygenase 1 (BCMO1) into two molecules of all-trans retinal, which subsequently can be oxidised to retinoic acid, or reduced to retinol [13]. There was however no substantial increase in plasma retinol during the 10 h to indicate high conversion (Fig. 1). Dietary factors can affect the activity of BCMO1, resulting in more or less of the absorbed β-carotene being converted [13]. It has been found that higher fat intake increases the post-absorptive conversion of β-carotene. The hepatic vitamin A content of gerbils fed on a 30% fat diet was significantly elevated compared to those fed on a 10% fat diet [24] and vitamin A levels in several tissues (liver, lung, kidney, adipose tissue, and testis) of ferrets fed a diet containing 23% fat was elevated compared with those fed a 6% fat diet [25]. It is possible that the very high fat content of the diet (18 g meal−1) could have increased the conversion of the absorbed β-carotene, resulting in decreased post-prandial response.

Effect of food matrix factors on β-carotene bioaccessibility

The low bioaccessibility of the β-carotene from the test meal, compare to digestion with olive oil, could be due to food matrix factors.

While fibre is a well-known inhibitor of carotenoid bioavailability [9], the fibre content of < 1% (2.7 g meal−1) was lower than the amounts (≈8–10 g) that has been reported to decrease β-carotene bioavailability [26].

The dairy based breakfast test meal (Table 1) also contained approximately 200 mg calcium (calculated from nutritional labelling on packaging), a divalent mineral which has also been found to decreased the micellization and cellular uptake of β-carotene in vitro [4]. While supplementing a meal with up to 1000 mg calcium did not decrease the β-carotene absorption in humans [7], a 500 mg supplement was found to decrease lycopene bioavailability with 83%[6]. While the calcium addition did not decrease the micellization of the lycopene, it did decrease the charge of the physiological mixed micelles.

The fatty acid profile of the dairy-based test meal could have affected the β-carotene micellization efficiency and/or absorption. While the majority of fatty acids in dairy are long chain fatty acids (LCFA; 86%), it also contains substantial amounts of short (SCFA; 5%) and medium chain fatty acids (MCFA; 9%) [27]. The TAG, β-carotene and retinyl-palmitate responses in the TRF of 16 young healthy men were found to be dramatically impaired when β-carotene was consumed with only MCFA compared to with LCFA [28]. This was explained by MCFA not eliciting the chylomicron response required for β-carotene absorption, as MCFA are almost exclusively transported via the portal vein. In the current study, however, the MCFA made up less than 10% of the fat consumed and the substantial plasma TAG response observed (Supplemental Tables A1 and A3) suggests that enough chylomicrons were produced to facilitate, if not all, a substantial amount of β-carotene transport into the lymphatic system.

When digested with the test meal, compared to olive oil, β-Carotene bioaccessibility was decreased more (78–84%), than β-carotene solubilisation (27–47%) (Table 4), suggesting that larger lipid vesicles formed, which were removed after filtration (200 nm). In the study by Borel et al. [28] decreased TRF β-carotene concentration after consumption of a MCFA vs. a LCFA rich meal was attributed to less β-carotene being absorbed into the enterocytes, because less was packaged into MCFA micelles compared to LCFA micelles. Salvia-Trujillo et al. [29] evaluated the effect of the fatty acid chain length on the in vitro bioaccessibility of β-carotene. They also observed a sixfold decrease in in vitro bioaccessibility of β-carotene when the lipid profile was changed from 100% LCFA to 100% MCFA. This was attributed to the easier incorporation of the long chain non-polar β-carotene into micelles formed by LCFA. They also proposed that β-carotene digested with LCFA is better solubilized within the mixed micelles, because during digestion with MCFA, β-carotene is trapped within larger vesicles that are less likely to be absorbed by enterocytes [30].

A large proportion (60%) of the total protein (14 g) in the meal was from the dairy products (yoghurt and cream cheese), which could have decreased the β-carotene solubilisation and subsequent bioaccessibility. Proteins play an important and varied effect in β-carotene bioavailability. While low protein status has been found to decrease intestinal cleavage of β-carotene [31], the low bioavailability of β-carotene from plant sources has, in part, been attributed to the it being bound to intrinsic plant proteins[32], which is not the case with Supplements. It is however possible that the proteins from the food matrix could interact with the supplemental β-Carotene during digestion [33]. In a study evaluating the food matrix effect on β-Carotene bioaccessibility, the β-Carotene bioaccessibility from fat-free yogurt was found to be fivefold lower than that from a fat-free tapioca pudding [34]. This was attributed to (1) coagulation of the yogurt proteins during the digestion, (2) the higher protein content of the yogurt, which decreased the solubilisation of β-carotene into the lipid phase and (3) the high casein content, which has been found to bind bile salts, decreasing the extent of micelle formation [9]. In rats it has also been found that soluble casein proteins can inhibit the incorporation of β-carotene into micelles, possibly due reducing enzyme access to the lipid droplets[35].

Concluding remarks

Despite the limitations of the human study (small number of participants and lack of post-prandial β-carotene response), the work still provides valuable insights into the possible role of the food matrix factors in β-carotene bioaccessibility and post-prandial conversion. It also provides important information for the successful planning of future studies. The dairy-based food matrix seems to have played a significant role in the low bioavailability of the β-carotene from the test-meal. First, the very high fat content of a meal could result in a high post-absorptive conversion of β-carotene to retinol. Secondly, while no constituent of the meal alone (high fat content, MCFA, fibre, calcium or casein) fully explains the lack of response in TRF β-carotene, the combined effects and/or interactions between some of the constituents could. The interactions of β-carotene and modulators of its bioavailability within dairy-based food matrices require more research.

Supplementary Information

Below is the link to the electronic supplementary material.Supplementary file1 (PDF 150 KB)

Abbreviations

TRF Triacylglycerol rich fraction

TAG Triacylglycerol

FaSSIF Fasted state simulated intestinal fluid

AUC Area under the plasma concentration–time curve

Cmax Maximum concentration in plasma

Tmax Time to reach the maximum concentration in plasma

LCFA Long chain fatty acids

SCFA Short chain fatty acids

MCFA Medium chain fatty acids

SFA Saturated fatty acids m

MUFA Monounsaturated fatty acids

PUFA Polyunsaturated fatty acids

BCMO1 β,β-Carotene 15,15’-monooxygenase 1

Acknowledgements

This research and J. Kruger were supported by a Georg Forster Research Fellowship from the Alexander von Humboldt Foundation, who was not involved in the study design or collection, analysis and interpretation of data, in the writing of the report and/or the decision to submit the article for publication.

Author contributions

Johanita Kruger: Conceptualization, Methodology, Investigation, Formal analysis, Writing—Original Draft, Writing—Review & Editing, Visualization, Supervision, Project administration, Funding acquisition. Nadine Sus: Methodology, Investigation, Supervision, Project administration. Andrea Moser: Investigation Sophie Scholz: Investigation. Guenther Adler: Investigation. Sascha Venturelli: Investigation. Jan Frank: Conceptualization, Writing—Review & Editing, Supervision, Project administration.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Declarations

Conflict of interest

The authors declare that they do not have any conflict of interest.

Informed consent

Written informed consent was obtained from all study participants.
==== Refs
References

1. Rao AV Rao LG Carotenoids and human health Pharmacol Res 2007 55 207 216 10.1016/j.phrs.2007.01.012 17349800
Rao AV, Rao LG (2007) Carotenoids and human health. Pharmacol Res 55:207–216. 10.1016/j.phrs.2007.01.01217349800 10.1016/j.phrs.2007.01.012
2. Zhao LG Zhang QL Zheng JL Dietary, circulating beta-carotene and risk of all-cause mortality: A meta-analysis from prospective studies Sci Rep 2016 10.1038/srep26983 28009010
Zhao LG, Zhang QL, Zheng JL et al (2016) Dietary, circulating beta-carotene and risk of all-cause mortality: A meta-analysis from prospective studies. Sci Rep. 10.1038/srep2698328009010 10.1038/srep26983
3. Bengtsson A Scheers N Andlid T Impaired uptake of β-carotene by Caco-2 human intestinal cells in the presence of iron Int J Food Sci Nutr 2009 60 125 135 10.1080/09637480802641270 19194811
Bengtsson A, Scheers N, Andlid T et al (2009) Impaired uptake of β-carotene by Caco-2 human intestinal cells in the presence of iron. Int J Food Sci Nutr 60:125–135. 10.1080/0963748080264127019194811 10.1080/09637480802641270
4. Biehler E Hoffmann L Krause E Bohn T Divalent minerals decrease micellarization and uptake of carotenoids and digestion products into caco-2 cells J Nutr 2011 141 1769 1776 10.3945/jn.111.143388 21865558
Biehler E, Hoffmann L, Krause E, Bohn T (2011) Divalent minerals decrease micellarization and uptake of carotenoids and digestion products into caco-2 cells. J Nutr 141:1769–1776. 10.3945/jn.111.14338821865558 10.3945/jn.111.143388
5. Kruger J Stuetz W Frank J Iron, catechin, and ferulic acid inhibit cellular uptake of β-carotene by reducing micellization J Agric Food Chem 2019 10.1021/acs.jafc.9b01417 31199652
Kruger J, Stuetz W, Frank J (2019) Iron, catechin, and ferulic acid inhibit cellular uptake of β-carotene by reducing micellization. J Agric Food Chem. 10.1021/acs.jafc.9b0141731199652 10.1021/acs.jafc.9b01417
6. Borel P Desmarchelier C Dumont U Dietary calcium impairs tomato lycopene bioavailability in healthy humans Br J Nutr 2017 116 2091 2096 10.1017/S0007114516004335
Borel P, Desmarchelier C, Dumont U et al (2017) Dietary calcium impairs tomato lycopene bioavailability in healthy humans. Br J Nutr 116:2091–2096. 10.1017/S000711451600433510.1017/S0007114516004335
7. Corte-Real J Guignard C Gantenbein M No influence of supplemental dietary calcium intake on the bioavailability of spinach carotenoids in humans Br J Nutr 2017 117 1560 1569 10.1017/S0007114517001532 28651681
Corte-Real J, Guignard C, Gantenbein M et al (2017) No influence of supplemental dietary calcium intake on the bioavailability of spinach carotenoids in humans. Br J Nutr 117:1560–1569. 10.1017/S000711451700153228651681 10.1017/S0007114517001532
8. Kopec RE Caris-Veyrat C Nowicki M The effect of an iron supplement on lycopene metabolism and absorption during digestion in healthy humans Mol Nutr Food Res 2019 63 1 10 10.1002/mnfr.201900644
Kopec RE, Caris-Veyrat C, Nowicki M et al (2019) The effect of an iron supplement on lycopene metabolism and absorption during digestion in healthy humans. Mol Nutr Food Res 63:1–10. 10.1002/mnfr.20190064410.1002/mnfr.201900644
9. Goltz SR Ferruzzi MG Tanumihardjo SA Carotenoids and human health Carotenoids and human health 2013 Totowa Humana Press 1 331
Goltz SR, Ferruzzi MG (2013) Carotenoids and human health. In: Tanumihardjo SA (ed) Carotenoids and human health. Humana Press, Totowa, pp 1–331
10. Zhou JR Gugger ET Jr The crystalline form of carotenes and the food matrix in carrot root decrease the relative bioavailability of beta- and alpha-carotene in the ferret model J Am Coll Nutr 1996 10.1080/07315724.1996.10718569 8632121
Zhou JR, Gugger ET Jr (1996) The crystalline form of carotenes and the food matrix in carrot root decrease the relative bioavailability of beta- and alpha-carotene in the ferret model. J Am Coll Nutr. 10.1080/07315724.1996.107185698632121 10.1080/07315724.1996.10718569
11. Goltz SR Campbell WW Chitchumroonchokchai C Meal triacylglycerol profile modulates postprandial absorption of carotenoids in humans Mol Nutr Food Res 2012 56 866 877 10.1002/mnfr.201100687 22707262
Goltz SR, Campbell WW, Chitchumroonchokchai C et al (2012) Meal triacylglycerol profile modulates postprandial absorption of carotenoids in humans. Mol Nutr Food Res 56:866–877. 10.1002/mnfr.20110068722707262 10.1002/mnfr.201100687
12. Priyadarshani AMB A review on factors influencing bioaccessibility and bioefficacy of carotenoids Crit Rev Food Sci Nutr 2017 57 1710 1717 10.1080/10408398.2015.1023431 26168011
Priyadarshani AMB (2017) A review on factors influencing bioaccessibility and bioefficacy of carotenoids. Crit Rev Food Sci Nutr 57:1710–1717. 10.1080/10408398.2015.102343126168011 10.1080/10408398.2015.1023431
13. Lietz G Lange J Rimbach G Molecular and dietary regulation of β, β-carotene 15,15′-monooxygenase 1 (BCMO1) Arch Biochem Biophys 2010 502 8 16 10.1016/j.abb.2010.06.032 20599666
Lietz G, Lange J, Rimbach G (2010) Molecular and dietary regulation of β, β-carotene 15,15′-monooxygenase 1 (BCMO1). Arch Biochem Biophys 502:8–1620599666 10.1016/j.abb.2010.06.032
14. Scales DC Rubenfeld GD Estimating sample size in critical care clinical trials J Crit Care 2005 20 6 11 10.1016/j.jcrc.2005.02.002 16015511
Scales DC, Rubenfeld GD (2005) Estimating sample size in critical care clinical trials. J Crit Care 20:6–11. 10.1016/j.jcrc.2005.02.00216015511 10.1016/j.jcrc.2005.02.002
15. Forman MR Johnson EJ Lanza E Effect of menstrual cycle phase on the concentration of individual carotenoids in lipoproteins of premenopausal women: a controlled dietary study Am J Clin Nutr 1998 67 81 87 10.1093/ajcn/67.1.81 9440379
Forman MR, Johnson EJ, Lanza E et al (1998) Effect of menstrual cycle phase on the concentration of individual carotenoids in lipoproteins of premenopausal women: a controlled dietary study. Am J Clin Nutr 67:81–87. 10.1093/ajcn/67.1.819440379 10.1093/ajcn/67.1.81
16. Forman MR Beecher GR Muesing R The fluctuation of plasma carotenoid concentrations by phase of the menstrual cycle: a controlled diet study Am J Clin Nutr 1996 64 559 565 10.1093/ajcn/64.4.559 8839500
Forman MR, Beecher GR, Muesing R et al (1996) The fluctuation of plasma carotenoid concentrations by phase of the menstrual cycle: a controlled diet study. Am J Clin Nutr 64:559–565. 10.1093/ajcn/64.4.5598839500 10.1093/ajcn/64.4.559
17. Stuetz W Weber D Dollé MET Plasma carotenoids, tocopherols, and retinol in the age-stratified (35–74 years) general population: a cross-sectional study in six European countries Nutrients 2016 10.3390/nu8100614 27706032
Stuetz W, Weber D, Dollé MET et al (2016) Plasma carotenoids, tocopherols, and retinol in the age-stratified (35–74 years) general population: a cross-sectional study in six European countries. Nutrients. 10.3390/nu810061427706032 10.3390/nu8100614
18. Frank J Schiborr C Kocher A Transepithelial transport of curcumin in Caco-2 cells is significantly enhanced by micellar solubilisation Plant Foods Hum Nutr 2017 72 48 53 10.1007/s11130-016-0587-9 27900602
Frank J, Schiborr C, Kocher A et al (2017) Transepithelial transport of curcumin in Caco-2 cells is significantly enhanced by micellar solubilisation. Plant Foods Hum Nutr 72:48–53. 10.1007/s11130-016-0587-927900602 10.1007/s11130-016-0587-9
19. O’Sullivan SM Woods JA O’Brien NM Use of Tween 40 and Tween 80 to deliver a mixture of phytochemicals to human colonic adenocarcinoma cell (CaCo-2) monolayers Br J Nutr 2004 91 757 764 10.1079/bjn20041094 15137928
O’Sullivan SM, Woods JA, O’Brien NM (2004) Use of Tween 40 and Tween 80 to deliver a mixture of phytochemicals to human colonic adenocarcinoma cell (CaCo-2) monolayers. Br J Nutr 91:757–764. 10.1079/bjn2004109415137928 10.1079/bjn20041094
20. Jogia H Prakash Sola S Kumar Garg L A simple, safe, and environmentally friendly method of FaSSIF and FeSSIF preparation without methylene chloride Dissolut Technol 2014 21 45 48 10.14227/DT210114P45
Jogia H, Prakash Sola S, Kumar Garg L et al (2014) A simple, safe, and environmentally friendly method of FaSSIF and FeSSIF preparation without methylene chloride. Dissolut Technol 21:45–48. 10.14227/DT210114P4510.14227/DT210114P45
21. Krishna G Chen KJ Lin CC Nomeir AA Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2 Int J Pharm 2001 222 77 89 10.1016/S0378-5173(01)00698-6 11404034
Krishna G, Chen KJ, Lin CC, Nomeir AA (2001) Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int J Pharm 222:77–89. 10.1016/S0378-5173(01)00698-611404034 10.1016/S0378-5173(01)00698-6
22. Rodrigues DB Chitchumroonchokchai C Mariutti LRB Comparison of two static in vitro digestion methods for screening the bioaccessibility of carotenoids in fruits, vegetables, and animal products J Agric Food Chem 2017 65 11220 11228 10.1021/acs.jafc.7b04854 29205039
Rodrigues DB, Chitchumroonchokchai C, Mariutti LRB et al (2017) Comparison of two static in vitro digestion methods for screening the bioaccessibility of carotenoids in fruits, vegetables, and animal products. J Agric Food Chem 65:11220–11228. 10.1021/acs.jafc.7b0485429205039 10.1021/acs.jafc.7b04854
23. Lobo GP Hessel S Eichinger A ISX is a retinoic acid-sensitive gatekeeper that controls intestinal β, β-carotene absorption and vitamin A production FASEB J 2010 24 1656 1666 10.1096/fj.09-150995 20061533
Lobo GP, Hessel S, Eichinger A et al (2010) ISX is a retinoic acid-sensitive gatekeeper that controls intestinal β, β-carotene absorption and vitamin A production. FASEB J 24:1656–1666. 10.1096/fj.09-15099520061533 10.1096/fj.09-150995
24. Deming DM Boileau AC Lee CM Erdman JW Amount of dietary fat and type of soluble fiber independently modulate postabsorptive conversion of β-carotene to vitamin A in Mongolian gerbils J Nutr 2000 130 2789 2796 10.1093/jn/130.11.2789 11053522
Deming DM, Boileau AC, Lee CM, Erdman JW (2000) Amount of dietary fat and type of soluble fiber independently modulate postabsorptive conversion of β-carotene to vitamin A in Mongolian gerbils. J Nutr 130:2789–2796. 10.1093/jn/130.11.278911053522 10.1093/jn/130.11.2789
25. Lakshman MR Liu QH Sapp R The effects of dietary taurocholate, fat, protein, and carbohydrate on the distribution and fate of dietary β-carotene in ferrets Nutr Cancer 1996 26 49 61 10.1080/01635589609514462 8844721
Lakshman MR, Liu QH, Sapp R et al (1996) The effects of dietary taurocholate, fat, protein, and carbohydrate on the distribution and fate of dietary β-carotene in ferrets. Nutr Cancer 26:49–61. 10.1080/016355896095144628844721 10.1080/01635589609514462
26. Hoffmann J Linseisen J Riedl J Wolfram G Dietary fiber reduces the antioxidative effect of a carotenoid and α- tocopherol mixture on LDL oxidation ex vivo in humans Eur J Nutr 1999 38 278 285 10.1007/s003940050078 10784384
Hoffmann J, Linseisen J, Riedl J, Wolfram G (1999) Dietary fiber reduces the antioxidative effect of a carotenoid and α- tocopherol mixture on LDL oxidation ex vivo in humans. Eur J Nutr 38:278–285. 10.1007/s00394005007810784384 10.1007/s003940050078
27. Markiewicz-Keszycka M Czyzak-Runowska G Lipinska P Wójtowski J Fatty acid profile of milk—a review Bull Vet Inst Pulawy 2013 57 135 139 10.2478/bvip-2013-0026
Markiewicz-Keszycka M, Czyzak-Runowska G, Lipinska P, Wójtowski J (2013) Fatty acid profile of milk—a review. Bull Vet Inst Pulawy 57:135–139. 10.2478/bvip-2013-002610.2478/bvip-2013-0026
28. Borel P Tyssandier V Mekki N Chylomicron β-carotene and retinyl palmitate responses are dramatically diminished when men ingest β-carotene with medium-chain rather than long- chain triglycerides J Nutr 1998 128 1361 1367 10.1093/jn/128.8.1361 9687557
Borel P, Tyssandier V, Mekki N et al (1998) Chylomicron β-carotene and retinyl palmitate responses are dramatically diminished when men ingest β-carotene with medium-chain rather than long- chain triglycerides. J Nutr 128:1361–1367. 10.1093/jn/128.8.13619687557 10.1093/jn/128.8.1361
29. Salvia-Trujillo L Qian C Martín-Belloso O McClements DJ Modulating β-carotene bioaccessibility by controlling oil composition and concentration in edible nanoemulsions Food Chem 2013 139 878 884 10.1016/j.foodchem.2013.02.024 23561185
Salvia-Trujillo L, Qian C, Martín-Belloso O, McClements DJ (2013) Modulating β-carotene bioaccessibility by controlling oil composition and concentration in edible nanoemulsions. Food Chem 139:878–884. 10.1016/j.foodchem.2013.02.02423561185 10.1016/j.foodchem.2013.02.024
30. Qian C Decker EA Xiao H McClements DJ Nanoemulsion delivery systems: Influence of carrier oil on β-carotene bioaccessibility Food Chem 2012 135 1440 1447 10.1016/j.foodchem.2012.06.047 22953878
Qian C, Decker EA, Xiao H, McClements DJ (2012) Nanoemulsion delivery systems: Influence of carrier oil on β-carotene bioaccessibility. Food Chem 135:1440–1447. 10.1016/j.foodchem.2012.06.04722953878 10.1016/j.foodchem.2012.06.047
31. Gronowska-Senger A, Wolf G (2023) Effect of dietary protein on the enzyme from rat and human intestine which converts ÃŸ-caroteneto retinal 1/2
32. Maurya VK Singh J Ranjan V Factors affecting the fate of β-carotene in the human gastrointestinal tract: a narrative review Int J Vitam Nutr Res 2022 92 385 405 32781911
Maurya VK, Singh J, Ranjan V et al (2022) Factors affecting the fate of β-carotene in the human gastrointestinal tract: a narrative review. Int J Vitam Nutr Res 92:385–40532781911
33. Iddir M Vahid F Merten D Influence of proteins on the absorption of lipophilic vitamins, carotenoids and curcumin—a review Mol Nutr Food Res 2022 66 2200076 10.1002/mnfr.202200076
Iddir M, Vahid F, Merten D et al (2022) Influence of proteins on the absorption of lipophilic vitamins, carotenoids and curcumin—a review. Mol Nutr Food Res 66:220007610.1002/mnfr.202200076
34. Donhowe EG Flores FP Kerr WL Characterization and invitro bioavailability of β-carotene: Effects of microencapsulation method and food matrix LWT Food Sci Technol 2014 57 42 48 10.1016/j.lwt.2013.12.037
Donhowe EG, Flores FP, Kerr WL et al (2014) Characterization and invitro bioavailability of β-carotene: Effects of microencapsulation method and food matrix. LWT Food Sci Technol 57:42–48. 10.1016/j.lwt.2013.12.03710.1016/j.lwt.2013.12.037
35. Hosotani H Kitagawa K Effects of dietary protein, fat and beta-carotene levels on beta-carotene absorption in rats Intl J Vit Nutr Res 2005 75 274 280 10.1024/0300-9831.75.4.274
Hosotani, Kitagawa (2005) Effects of dietary protein, fat and beta-carotene levels on beta-carotene absorption in rats. Intl J Vit Nutr Res 75:274–280. 10.1024/0300-9831.75.4.27410.1024/0300-9831.75.4.274
